WA
INSM icon

WPG Advisers’s Insmed INSM Stock Holding History

WPG Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.97K Sell
56
-43
-43% -$5.21K ﹤0.01% 925
2026
Q1 		$16.2K Sell
99
-19
-16% -$2.92K 0.01% 536
2025
Q4 		$20.5K Sell
118
-1
-0.8% -$182 0.02% 499
2025
Q3 		$17.1K Sell
119
-11
-8% -$1.35K 0.01% 540
2025
Q2 		$13.1K Buy
130
+18
+16% +$1.38K 0.01% 591
2025
Q1 		$8.54K Sell
112
-2
-2% -$153 0.01% 683
2024
Q4 		$7.87K Buy
+114
New +$8.21K 0.01% 706

Other funds holding INSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

WPG Advisers's INSM Position: Q2 2026 in Review

WPG Advisers reduced its Insmed (INSM) stake by 43% in Q2 2026, selling an estimated $5.21K and leaving 56 shares worth $5.97K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

WPG Advisers first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $20.5K in Q4 2025. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • WPG Advisers held 56 shares of Insmed worth $5.97K as of Q2 2026.
  • WPG Advisers sold 43 Insmed shares in Q2 2026, an estimated $5.21K.
  • Insmed made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #925 holding.
  • WPG Advisers first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Insmed position peaked at $20.5K in Q4 2025.
  • 281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.